Literature DB >> 700281

Diminished gastrointestinal potentiation of insulin secretion in human pregnancy.

P Hornnes, C Kühl, J G Klebe.   

Abstract

In order to investigate whether an increased gastrointestinal potentiation of glucose-induced insulin release might be involved in the enhanced insulin response to oral glucose in pregnancy, seven normal women were subjected to an oral glucose tolerance test (OGTT) and an IV glucose infusion test (IVGI) in the last trimester of pregnancy and again four to ten weeks post-partum. The amount of glucose administered intravenously was adjusted to obtain plasma glucose concentrations similar to those of the preceding OGTT. By this technique it was possible to quantitate the amount of insulin release attributable to gastrointestinal factors. Contrary to expectations, the results revealed that the gastrointestinal potentiation of insulin secretion was reduced by more than 75% in late pregnancy (p less than 0.05). The hyperinsulinaemia of pregnancy is therefore not explained by an increased activity of the entero-insular axis. Moreover the results confirm a substantially increased beta cell sensitivity to a glycaemic stimulus in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 700281     DOI: 10.1007/bf00421233

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  CARBOHYDRATE METABOLISM IN PREGNANCY. V. THE INTERRELATIONS OF GLUCOSE, INSULIN AND FREE FATTY ACIDS IN LATE PREGNANCY AND POST PARTUM.

Authors:  S J BLEICHER; J B O'SULLIVAN; N FREINKEL
Journal:  N Engl J Med       Date:  1964-10-22       Impact factor: 91.245

2.  PLASMA INSULIN IN NORMAL "EARLY" PREGNANCY.

Authors:  W N SPELLACY; F C GOETZ; B Z GREENBERG; J ELLS
Journal:  Obstet Gynecol       Date:  1965-06       Impact factor: 7.661

3.  PREGNANCY AND DIABETES, MEDICAL ASPECTS.

Authors:  P WHITE
Journal:  Med Clin North Am       Date:  1965-07       Impact factor: 5.456

4.  Effect of normal pregnancy on glucose assimilation, insulin and non-esterified fatty acids levels.

Authors:  C Picard; H A Ooms; E Balasse; V Conard
Journal:  Diabetologia       Date:  1968-01       Impact factor: 10.122

Review 5.  Entero-insular axis.

Authors:  R H Unger; A M Eisentraut
Journal:  Arch Intern Med       Date:  1969-03

6.  Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro.

Authors:  P Schauder; J C Brown; H Frerichs; W Creutzfeldt
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

7.  Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose.

Authors:  C Kühl
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

8.  The enteral insulin-stimulation after pancreas transplantation in the pig.

Authors:  S L Jensen; O V Nielsen; C Kühl
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

9.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.

Authors:  J Dupre; J D Curtis; R H Unger; R W Waddell; J C Beck
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  2 in total

1.  A study on the hyperinsulinism of late pregnancy.

Authors:  I Piva; G Erle; M Thiella; L Lora; M Strazzabosco; N Sicolo; G Federspil
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

2.  Response to Letter to the Editor From Göbl and Tura: "Oral Glucose Tolerance Test-based Measures of Insulin Secretory Response in Pregnancy".

Authors:  Camille E Powe; Joseph J Locascio; Jose C Florez; Patrick M Catalano
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.